Holland Katherine Alice Boden
CIK 1695948 · View on SEC EDGAR ↗
First SEC filing: Nov. 9, 2017 · Latest: Nov. 9, 2017
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2021 | CVSA | P | 611 | $40.94 | $25,014 | 27,511 Direct | +2.27% | Acquired | 212.2% (price as of 2026-08-21) |
| Nov. 11, 2019 | CVSA | P | 2,000 | $31.99 | $63,980 | 16,367 Direct | +13.92% | Acquired | 299.5% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 26, 2020 | CVSA | Employee Stock Option (Right to Buy) | Common Stock (26,775) | $32.03 | Aug. 26, 2030 | 26,775 | Acquired |
| Aug. 28, 2019 | CVSA | Employee Stock Option (Right to Buy) | Common Stock (19,400) | $43.39 | Aug. 28, 2029 | 19,400 | Acquired |
| Aug. 22, 2018 | CVSA | Non-qualified Stock Option (Right to Buy) [F2] | Common Stock (7,323) | $49.05 | Aug. 22, 2028 | 7,323 | Acquired |
| Aug. 22, 2018 | CVSA | Incentive Stock Option (Right to Buy) [F2] | Common Stock (8,152) | $49.05 | Aug. 22, 2028 | 8,152 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).